Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.72
-0.0100-0.58%
Post-market: 1.720.00000.00%16:54 EDT
Volume:164.98K
Turnover:285.57K
Market Cap:76.35M
PE:-2.68
High:1.75
Open:1.70
Low:1.70
Close:1.73
Loading ...

ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination

TIPRANKS
·
10 May

ESSA Pharma Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
09 May

BRIEF-ESSA Pharma Reports Financial Results For Fiscal Second Quarter Ended March 31, 2025

Reuters
·
08 May

ESSA Pharma Q2 EPS $(0.14) Beats $(0.19) Estimate

Benzinga
·
08 May

ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

THOMSON REUTERS
·
08 May

ESSA Pharma Inc - Continues to Evaluate Strategic Options

THOMSON REUTERS
·
08 May

ESSA Pharma Inc - Reports $6.4 Million Net Loss for Q2 2025

THOMSON REUTERS
·
08 May

ESSA Pharma Q2 Operating Expenses USD -7.381 Million

THOMSON REUTERS
·
08 May

ESSA Pharma Q2 Net Income USD -6.374 Million

THOMSON REUTERS
·
08 May

Press Release: ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

Dow Jones
·
08 May

Soleus Capital Master Fund-Believe It Is in Shareholders’ Best Interest for ESSA Pharma to Wind Down Operations,Return Remaining Cash to Shareholders

THOMSON REUTERS
·
16 Apr

Soleus Capital Master Fund, L.p. Reports 5.1 % Stake in ESSA Pharma Inc as of April 15 - SEC Filing

THOMSON REUTERS
·
16 Apr

Bvf Partners L P Says Purchased ESSA Pharma Securities Based on Belief That Such Securities, When Purchased, Were "Undervalued"

THOMSON REUTERS
·
09 Apr

Bvf Partners L P Reports 19.7% Stake in ESSA Pharma Inc as of April 9 - SEC Filing

THOMSON REUTERS
·
09 Apr

We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate

Simply Wall St.
·
01 Apr

EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc.

TIPRANKS
·
20 Mar

Press Release: ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

Dow Jones
·
06 Mar

ESSA Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Feb

ESSA Pharma Q1 2025 GAAP EPS $(0.19) Misses $(0.12) Estimate, Cash $120.6M

Benzinga
·
11 Feb

ESSA Pharma: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
11 Feb